Skip to main content
. 2020 Jul 7;11(4):e00972-20. doi: 10.1128/mBio.00972-20

FIG 4.

FIG 4

Isolation of a novel F129–137-specific TCC. (A) AQITAGIALPE tetramer fluorescence-activated cell sorting (FACS) staining of TCC CD8Xreact1 confirming that the TCC is CD8+ and recognizes FAQITAGIAL in the context of HLA-B*15:01. (B) CD3APCCy7 and AQITAGIALPE tetramer staining of PBMC obtained from three human HLA-B*15:01-positive donors. CD3+ CD8+ T cells that were positively stained by the HLA-B*15:01-AQITAGIAL tetramer were single cell sorted by FACS and clonally expanded from donor 3. (C) AQITAGIALPE tetramer FACS staining of TCC CD8Xreact2 confirming that the TCC is CD8+ and recognizes FAQITAGIAL in the context of HLA-B*15:01.